NAD+
NAD+ is a central redox coenzyme studied for mitochondrial signaling, aging biology, and cellular repair pathways.
What NAD+ is
NAD+ is not a peptide; it is a nucleotide-derived coenzyme used in virtually every cell. Research interest centers on its role in redox reactions, mitochondrial metabolism, sirtuin signaling, PARP activity, and age-associated changes in cellular energy handling. Education pages often group NAD+ with peptide protocols because it is sold in similar lyophilized formats, but mechanistically it belongs to metabolism and coenzyme biology.
Published human work most often studies NAD+ precursors such as nicotinamide riboside or nicotinamide mononucleotide, while direct NAD+ material appears in more limited pharmacokinetic and infusion-oriented discussions. Any research-grade NAD+ powder is Research Use Only and is not the same thing as a regulated drug product. Reported ranges below are reference points from published precursor or NAD-related literature, not instructions for use.
How it works
NAD+ cycles between oxidized and reduced forms to shuttle electrons through glycolysis, the TCA cycle, and oxidative phosphorylation. It also serves as a substrate for enzymes including sirtuins, PARPs, CD38, and other NAD-consuming systems. When NAD+ availability changes, downstream effects can include altered mitochondrial respiration, DNA damage signaling, inflammatory tone, and cellular stress responses. Researchers study both direct NAD+ and precursor strategies because cells tightly regulate NAD synthesis, salvage, and consumption.
The research context
NAD+ is studied by mitochondrial biologists, aging researchers, nutrition scientists, and pharmacologists. Clinical investigators more commonly study oral NAD+ precursors, while analytical labs examine NAD+ handling, stability, and compartment-specific measurement.
What the research examines
Research areas, not results. A topic on this list is being studied, not settled.
How it appears in the literature
What the published work actually used. Reference only, not instructions.
| Research context | Reported amount | Frequency | Route |
|---|---|---|---|
| Human oral nicotinamide riboside studies commonly cited in NAD+ precursor literature | 300 mg – 1000 mg | daily in study protocols | oral |
| Acute human cerebral NAD+ measurement study using nicotinamide riboside | 900 mg | single study dose | oral |
Handling & storage
Research-grade lyophilized NAD+ is commonly stored frozen and protected from moisture and light; reconstituted material is typically kept refrigerated and used promptly in laboratory settings.
Notes on combined research
NAD+ is often discussed beside mitochondrial and recovery-focused compounds, but the strongest literature is on NAD metabolism rather than peptide stacking. Researchers usually separate NAD+ or precursor variables from other interventions so changes in redox markers, methylation demand, and mitochondrial readouts can be interpreted cleanly.
NAD+ questions
For education only: published human studies most often report oral NAD+ precursor amounts, commonly in the hundreds of milligrams to 1 gram daily. That is not a recommendation and is not the same as dosing research-grade NAD+.
Research suppliers commonly discuss 5-20 mL reconstitution volumes for larger NAD+ vials, depending on target concentration. Reconstitution math is a lab calculation, not a human-use instruction.
Daily values in the literature usually refer to oral precursors such as nicotinamide riboside. Direct NAD+ protocols vary by research model and should be read from the original paper.
A useful chart should separate precursor studies, direct NAD+ analytical work, route, concentration, and species. Combining them into one dosing chart can be misleading.
Some precursor studies measure NAD-related metabolites within hours, while tissue or functional endpoints are usually assessed over weeks. Timing depends on the assay and model.
There is no single practical half-life for all NAD+ research because NAD+ is rapidly turned over and compartmentalized. Researchers often track metabolite pools rather than plasma half-life alone.
It can be studied alongside other compounds, but clean protocols isolate variables. Research-use-only material should not be treated as a wellness stack or drug substitute.
Read the research yourself
These references were validated against the NCBI database. No citation appears here unless it resolves to a real paper.
- Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions.PubMed
- Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD(+) in healthy middle-aged and older adults.PubMed
- Acute nicotinamide riboside supplementation increases human cerebral NAD(+) levels in vivo.PubMed